Trial | NCT00334711  Report issue

Title

Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations
A Prospective Study of Sulfonylureas in Patients With Diabetes Due to Kir6.2 Mutations

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    50
The purpose of this study is to investigate whether patients with diabetes due to Kir6.2 mutations can be treated with sulfonylurea medication rather than insulin, and if this is the case to investigate the mechanism for sulfonylurea response.
Study Started
Jan 31
2004
Study Completion
Jan 31
2006
Last Update
Nov 29
2006
Estimate

Drug Sulfonylurea

Criteria 

Inclusion Criteria:

Diabetes due to KCNJ11 (Kir6.2) mutation

Exclusion Criteria:

None
No Results Posted